---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-096734"
form_type: "8-K"
ticker: "NRIX"
cik: "0001549595"
company_name: "Nurix Therapeutics, Inc."
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T18:41:25.187210+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nurix Therapeutics ups ATM equity offering capacity to $413.65M

## Summary
- Amendment No. 3 to Equity Distribution Agreement with Piper Sandler dated March 6, 2026.
- Maximum aggregate gross offering price of common stock increased from $300M to $413.65M.
- Shares offered at-the-market from time to time; prospectus supplement filed same day.
- Proceeds not specified; prior ATM sales included in the increased limit.

## SEC filing metadata
- accession: 0001193125-26-096734
- form_type: 8-K
- ticker: NRIX
- cik: 0001549595
- company_name: Nurix Therapeutics, Inc.
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549595/000119312526096734/0001193125-26-096734-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549595/000119312526096734/d32105d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-096734
- JSON: https://secwatch.observer/filing/0001193125-26-096734.json
- Plain text: https://secwatch.observer/filing/0001193125-26-096734.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.